Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Borgna‐Pignatti, C., Rugolotto, S., Stefano, P. D., Zhao, H., Cappellini, M. D., Vecchio, G. C. D., Romeo, M. A., Forni, G. L., Gamberini, M. R., Ghilardi, R., et al. (2004) · PubMed · Cited by 1,119 · see citing works

MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients

Wood, J. C., Enriquez, C. M., Ghugre, N. R., Tyszka, J. M., Carson, S., Nelson, M. D., & Coates, T. D. (2005) · Blood · doi:10.1182/blood-2004-10-3982 · Cited by 1,043 · see citing works

Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance

Pierre, T. G. S., Clark, P. R., Chua‐anusorn, W., Fleming, A. J., Jeffrey, G. P., Olynyk, J. K., Pootrakul, P., Robins, E., & Lindeman, R. (2004) · Blood · doi:10.1182/blood-2004-01-0177 · Cited by 905 · see citing works

Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major

Brittenham, G. M., Griffith, P. M., Nienhuis, A. W., McLaren, C. E., Young, N. S., Tucker, E. E., Allen, C. J., Farrell, D. E., & Harris, J. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310902 · Cited by 822 · see citing works

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

Modell, B., Khan, M., Darlison, M. W., Westwood, M. A., Ingram, D., & Pennell, D. J. (2008) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-10-42 · Cited by 595 · see citing works

Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major

Kirk, P., Roughton, M., Porter, J. B., Walker, J. M., Tanner, M. A., Patel, J., Wu, D., Taylor, J., Westwood, M. A., Anderson, L., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.874487 · Cited by 595 · see citing works

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

Anderson, L. J., Wonke, B., Prescott, E., Holden, S., Walker, J. M., & Pennell, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09740-4 · Cited by 431 · see citing works

Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions

Olivieri, N. F., Buncic, J. R., Chew, E., Gallant, T., Harrison, R. V., Keenan, N. K., Logan, W. J., Mitchell, D., Ricci, G., Skarf, B., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604033141402 · Cited by 425 · see citing works

Survival and Complications in Thalassemia

Borgna‐Pignatti, C., Cappellini, M. D., Stefano, P. D., Vecchio, G., FORNI, G. L., Gamberini, M. R., Ghilardi, R., Origa, R., Piga, A. G., Romeo, M. A., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.006 · Cited by 422 · see citing works

Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent

Singer, S. T., Wu, V., Mignacca, R. C., Kuypers, F. A., Morel, P. A., & Vichinsky, E. P. (2000) · Blood · doi:10.1182/blood.v96.10.3369 · Cited by 362 · see citing works

Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease

Wood, J. C., Tyszka, J. M., Carson, S., Nelson, M. D., & Coates, T. D. (2003) · Blood · doi:10.1182/blood-2003-06-1919 · Cited by 338 · see citing works

The Prevention of ThalassemiaPreprint

Cao, A., & Kan, Y. W. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011775 · Cited by 295 · see citing works

Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Vogiatzi, M. G., Macklin, E. A., Fung, E. B., Cheung, A. M., Vichinsky, E. P., Olivieri, N. F., Kirby-Allen, M. A., Kwiatkowski, J. L., Cunningham, M. J., Holm, I. A., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080505 · Cited by 254 · see citing works

Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major

Farmaki, K., Tzoumari, I., Pappa, C., Chouliaras, G. L., & Berdoukas, V. A. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07970.x · Cited by 252 · see citing works

Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling

Locatelli, F., Kabbara, N., Ruggeri, A., Ghavamzadeh, A., Roberts, I., Li, C. K., Bernaudin, F., Vermylen, C., Dalle, J.-H., Stein, J., et al. (2013) · Blood · doi:10.1182/blood-2013-03-489112 · Cited by 244 · see citing works

Hepatic iron concentration combined with long‐term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major

Telfer, P. T., Prestcott, E., Holden, S., Walker, J. M., Hoffbrand, A. V., & Wonke, B. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02298.x · Cited by 238 · see citing works

Longitudinal analysis of heart and liver iron in thalassemia major

Noetzli, L. J., Carson, S., Nørd, A., Coates, T. D., & Wood, J. C. (2008) · Blood · doi:10.1182/blood-2008-04-148767 · Cited by 220 · see citing works

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

Cappellini, M. D., Béjaoui, M., Ağaoğlu, L., Canatan, D., Capra, M., Cohen, A. R., Drelichman, G. I., Economou, M. P., Fattoum, S., Kattamis, A., et al. (2011) · Blood · doi:10.1182/blood-2010-11-316646 · Cited by 219 · see citing works

The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients

Ceci, A., Baiardi, P., Felisi, M., Cappellini, M. D., Carnelli, V., Sanctis, V. D., Galanello, R., Maggio, A., Masera, G., Piga, A. G., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03554.x · Cited by 214 · see citing works

Safety profile of the oral iron chelator deferiprone: a multicentre study

Cohen, Galanello, Piga, DiPalma, Vullo, & Tricta (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01866.x · Cited by 191 · see citing works

Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.

Telfer, P. T., Coen, P. G., Christou, S., Hadjigavriel, M., Kolnakou, A., Pangalou, E., Pavlides, N., Psiloines, M., Simamonian, K., Skordos, G., et al. (2006) · PubMed · Cited by 190 · see citing works

Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America

Vogiatzi, M. G., Macklin, E. A., Trachtenberg, F. L., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07793.x · Cited by 176 · see citing works

Challenges of alloimmunization in patients with haemoglobinopathies

Chou, S. T., Liem, R. I., & Thompson, A. A. (2012) · British Journal of Haematology · doi:10.1111/bjh.12061 · Cited by 173 · see citing works

RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients

Ameen, R. M., Alshemmari, S., Al-Humood, S. A., Chowdhury, R. I., Al‐Eyaadi, O., & Al‐Bashir, A. (2003) · Transfusion · doi:10.1046/j.1537-2995.2003.00549.x · Cited by 169 · see citing works

Pancreatic iron and glucose dysregulation in thalassemia major

Noetzli, L. J., Mittelman, S. D., Watanabe, R. M., Coates, T. D., & Wood, J. C. (2011) · American Journal of Hematology · doi:10.1002/ajh.22223 · Cited by 169 · see citing works

Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators

Al‐Refaie, F. N., Hershko, C., Hoffbrand, A. V., et al. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05274.x · Cited by 169 · see citing works

Long‐term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

Agarwal, M. B., Gupte, S. S., Viswanathan, C., et al. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb06445.x · Cited by 164 · see citing works

Advances in the allogeneic transplantation for thalassemia

Lucarelli, G., & Gaziev, J. (2007) · Blood Reviews · doi:10.1016/j.blre.2007.10.001 · Cited by 164 · see citing works

Vitamin C and Iron

Nienhuis, A. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101153040311 · Cited by 163 · see citing works

Complications of thalassemia major and their treatment

Borgna‐Pignatti, C., & Gamberini, M. R. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.29 · Cited by 161 · see citing works

Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage

Porter, J. B., Jaswon, M. S., Huehns, E. R., East, C. A., & Hazell, J. W. P. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb07761.x · Cited by 148 · see citing works

Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron.

Tanner, M. A., He, T., Westwood, M. A., et al. (2006) · PubMed · Cited by 148 · see citing works

Unrelated Bone Marrow Transplantation for β‐Thalassemia Patients: The Experience of the Italian Bone Marrow Transplant Group

Nasa, G. L., Argiolu, F., Giardini, C., Pession, A., Fagioli, F., Caocci, G., Vacca, A., Stefano, P. D., Piras, E., Ledda, A., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.023 · Cited by 144 · see citing works

Impact of Iron Assessment by MRI

Wood, J. C. (2011) · Hematology · doi:10.1182/asheducation-2011.1.443 · Cited by 142 · see citing works

Red cell alloimmunization in a diverse population of transfused patients with thalassaemia

Thompson, A. A., Cunningham, M. J., Singer, S. T., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08576.x · Cited by 124 · see citing works

Red cell alloantibodies in thalassemia major

Sirchia, G., Zanella, A., Parravicini, A., et al. (1985) · Transfusion · doi:10.1046/j.1537-2995.1985.25285169198.x · Cited by 121 · see citing works

Quality of Life in Patients with Thalassemia Intermedia Compared to Thalassemia Major

Pakbaz, Z., Treadwell, M. J., YAMASHITA, R. C., Quirolo, K. C., Foote, D., Quill, L. M., SINGER, T., & Vichinsky, E. P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.059 · Cited by 112 · see citing works

Renal dysfunction in patients with thalassaemia

Quinn, C. T., Johnson, V. L., Kim, H., Trachtenberg, F. L., Vogiatzi, M. G., Kwiatkowski, J. L., Neufeld, E. J., Fung, E. B., Oliveri, N. F., Kirby-Allen, M. A., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08477.x · Cited by 109 · see citing works

Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: the ITHACA study

Scalone, L., Mantovani, L. G., Krol, M., Rofail, D., Ravera, S., Bisconte, M. G., Borgna‐Pignatti, C., Borsellino, Z., Cianciulli, P., Gallisai, D., et al. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802160834 · Cited by 108 · see citing works

ASCORBIC ACID ENHANCEMENT OF DESFERRIOXAMINE‐INDUCED URINARY IRON EXCRETION IN THALASSEMIA MAJOR*

O’Brien, R. T. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb20588.x · Cited by 101 · see citing works

Complications and treatment of patients with -thalassemia in France: results of the National Registry

Thuret, I., Pondarré, C., Loundou, A., Steschenko, D., Girot, R., Bachir, D., Rosé, C., Barlogis, V., Donadieu, J., de Montalembert, M., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.018051 · Cited by 101 · see citing works

Ocular changes in patients undergoing long-term desferrioxamine treatment.

Arden, G. B., Wonke, B., Kennedy, C., & Huehns, E. R. (1984) · British Journal of Ophthalmology · doi:10.1136/bjo.68.12.873 · Cited by 97 · see citing works

Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine

Sanctis, V. D., Pinamonti, A., Palma, A. D., et al. (1996) · European Journal of Pediatrics · doi:10.1007/bf01955263 · Cited by 96 · see citing works

Psychosocial aspects and psychiatric disorders in young adult with thalassemia major

Messina, G., Colombo, E. A., Cassinerio, E., et al. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0166-7 · Cited by 93 · see citing works

Hematopoietic Stem Cell Transplantation in Thalassemia

Angelucci, E. (2010) · Hematology · doi:10.1182/asheducation-2010.1.456 · Cited by 89 · see citing works

Quality of life in thalassemia: A comparison of SF‐36 results from the thalassemia longitudinal cohort to reported literature and the US norms

Sobota, A. E., YAMASHITA, R. C., Xu, Y., Trachtenberg, F. L., Kohlbry, P., Kleinert, D. A., Giardina, P. J., Kwiatkowski, J. L., Foote, D., Thayalasuthan, V., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21896 · Cited by 89 · see citing works

Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

Kwiatkowski, J. L., Kim, H.-Y., Thompson, A. A., et al. (2012) · Blood · doi:10.1182/blood-2011-04-344507 · Cited by 84 · see citing works

The Population Genetics and Dynamics of the Thalassemias

Weatherall, D. J., Williams, T. N., Allen, S. J., & O’Donnell, A. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.010 · Cited by 83 · see citing works

Reproductive capacity in iron overloaded women with thalassemia major

Singer, S. T., Vichinsky, E. P., Gildengorin, G. L., et al. (2011) · Blood · doi:10.1182/blood-2011-06-360271 · Cited by 77 · see citing works

Blood Transfusion and Alloimmunization in Patients with Thalassemia: Multicenter Study

Azarkeivan, A., Ansari, S., Ahmadi, M. H., et al. (2011) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2011.568595 · Cited by 77 · see citing works

Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population

Ladis, V., Chouliaras, G. L., Berdoukas, V. A., Chatziliami, A., Fragodimitri, C., Karabatsos, F., Youssef, J., Kattamis, A., & Karagiorga‐Lagana, M. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01582.x · Cited by 76 · see citing works

Real-World Use of Iron Chelators

Kwiatkowski, J. L. (2011) · Hematology · doi:10.1182/asheducation-2011.1.451 · Cited by 76 · see citing works

Deferiprone‐associated myelotoxicity

Al‐Refaie, F. N., Wonke, B., & Hoffbrand, A. V. (1994) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1994.tb01323.x · Cited by 71 · see citing works

Iron chelation therapy: Clinical effectiveness, economic burden and quality of life in patients with iron overload

Payne, K. A., Rofail, D., Baladi, J., et al. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0085-z · Cited by 68 · see citing works

Inadequate Dietary Intake in Patients with Thalassemia

Fung, E. B., Xu, Y., Trachtenberg, F. L., Odame, I., Kwiatkowski, J. L., Neufeld, E. J., Thompson, A. A., Boudreaux, J. M., Quinn, C. T., & Vichinsky, E. P. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.01.017 · Cited by 59 · see citing works

Update on fertility in thalassaemia major.

Skordis, N., Petrikkos, L., Toumba, M., et al. (2004) · PubMed · Cited by 47 · see citing works

Clinical and economic burden of infused iron chelation therapy in the United States

Payne, K. A., Desrosiers, M., Jaime, J., Baladi, J., Lordan, N. D., Proskorovsky, I., Ishak, K. J., & Rofail, D. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01398.x · Cited by 45 · see citing works

Relationship between Chronic Transfusion Therapy and Body Composition in Subjects with Thalassemia

Fung, E. B., Xu, Y., Kwiatkowski, J. L., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.04.064 · Cited by 45 · see citing works

Hypogonadotrophic Hypogonadism and Diminished Gonadal Reserve Accounts for Dysfunctional Gametogenesis in Thalassaemia Patients with Iron Overload Presenting with Infertility

Bajoria, R., & Chatterjee, R. (2011) · Hemoglobin · doi:10.3109/03630269.2011.623809 · Cited by 44 · see citing works

The effects of chelators on zinc levels in patients with thalassemia major

Erdogan, E. I., Canatan, D., Örmeci, A. R., et al. (2012) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2012.10.002 · Cited by 43 · see citing works

Characterization of low bone mass in young patients with thalassemia by DXA, pQCT and markers of bone turnover

Fung, E. B., Vichinsky, E. P., Kwiatkowski, J. L., et al. (2011) · Bone · doi:10.1016/j.bone.2011.03.765 · Cited by 43 · see citing works

Pain as an emergent issue in thalassemia

Trachtenberg, F. L., Foote, D., Martin, M., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21670 · Cited by 42 · see citing works

Two decades of pre-marital screening for beta-thalassemia in central Iran

Zeinalian, M., Nobari, R. F., Moafi, A., et al. (2013) · Journal of Community Genetics · doi:10.1007/s12687-013-0142-4 · Cited by 33 · see citing works

The effect of high-calorie diet on nutritional parameters of children with ?-thalassaemia major

Soliman, A. T. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.03.001 · Cited by 28 · see citing works

MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients

Nichols‐Vinueza, D., White, M. T., Powell, A. J., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23715 · Cited by 24 · see citing works

Nutritional support and growth in thalassaemia major

Fuchs, G. J., Tienboon, P., Khaled, M. A., et al. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.76.6.509 · Cited by 18 · see citing works

Insulin sensitivity assessment with euglycemic insulin clamp in adult β‐thalassaemia major patients

Τσάπας, Α., Vlachaki, E., Christoforidis, A., et al. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00966.x · Cited by 8 · see citing works

Pregnancy and beta-thalassemia: an Italian multicenter experience.

Origa, R., 佳奈江, 河., Quarta, G., 幸男, 門., 宏文, 立., 耕路, 山., & Galanello, R. (2010) · PubMed · doi:10.3324/haematol.2009.012393

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

Thompson, A. A., Walters, M. C., Kwiatkowski, J., Rasko, J. E. J., Ribeil, J.-A., Hongeng, S., Magrin, E., Schiller, G. J., Payen, E., Semeraro, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705342 · Cited by 684 · see citing works

From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice

Leahy, M. F., & Mukhtar, S. A. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02717.x · Cited by 68 · see citing works

Blood transfusion therapy for β‐thalassemia major and hemoglobin E β‐thalassemia: Adequacy, trends, and determinants in Sri Lanka

Mettananda, S., Pathiraja, H., Peiris, R., Wickramarathne, N., Bandara, D. C., de Silva, U., Mettananda, C. D., & Premawardhena, A. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27643 · Cited by 25 · see citing works

Serum erythropoietin levels in patients with thalassemia after blood transfusion

Zhu, F.-C. (2009) · Chinese Journal of Birth Health & Heredity

Do Transfusion Dependent E-Βeta Thalassemics Behave Differently from Patients with Βeta-Thalassemia Major?

Sen, S., Mohapatra, R., & Chakrabarti, P. (2021) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-021-01401-4

[Blood transfusion in thalassemia--the Jerusalem experience].

Aw, G., Stupp-DaCosta, Y., Manny, N., et al. (1985) · PubMed